Overview

Acceptability of Long-term Progestin-only Contraception in Europe

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The study examines the use of Mirena or Implanon for long-term contraception in women. The duration of therapy use is the key focus of the study. Also, any reasons for discontinuation and the safety profile will be examined. In addition, patients are asked to fill out a short questionnaire about their menstrual bleeding before and during therapy.
Details
Lead Sponsor:
Bayer
Treatments:
Etonogestrel
Levonorgestrel
Progestins